Dr. Douglas White’s research and award-winning communication initiatives are increasing both our understanding of rheumatic diseases and outcomes for patients.
While working at Waikato Hospital, Dr. White has enhanced knowledge of the diagnosis and treatment of rheumatic conditions. He has explored how skin changes can assist early, accurate confirmation of systemic sclerosis; genetic predisposition for gout and the role of ultrasound in diagnosis; as well as the prevalence of the HLA B27 gene marker for spondyloarthritis, the effects of smoking on the condition and its genetic associations with inflammatory bowel disease. He has collaborated in 29 clinical trials giving local rheumatology patients access to therapies not otherwise available in New Zealand. He also spearheaded an electronic referral/triage system, winning a Ko Awatea Excellence Award in 2015 and is a contributor to the PORTAL study, aiming to increase patient engagement in treatment.
Dr. Douglas White
Tactics for rheumatics
Waikato DHB Medical Science Award
Dr. Douglas White’s research and award-winning communication initiatives are increasing both our understanding of rheumatic diseases and outcomes for patients.
While working at Waikato Hospital, Dr. White has enhanced knowledge of the diagnosis and treatment of rheumatic conditions. He has explored how skin changes can assist early, accurate confirmation of systemic sclerosis; genetic predisposition for gout and the role of ultrasound in diagnosis; as well as the prevalence of the HLA B27 gene marker for spondyloarthritis, the effects of smoking on the condition and its genetic associations with inflammatory bowel disease. He has collaborated in 29 clinical trials giving local rheumatology patients access to therapies not otherwise available in New Zealand. He also spearheaded an electronic referral/triage system, winning a Ko Awatea Excellence Award in 2015 and is a contributor to the PORTAL study, aiming to increase patient engagement in treatment.